Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan medoxomil multiple-dose safety and PK in Chinese adults with hypertension
CTR20150603Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azilsartan medoxomil in essential hypertension, sponsored by Hengrui Therapeutics. Started Oct 2015; status: active.
02
Drugs
azilsartan medoxomil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20150603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150603.